Breaking News
First Topical Treatment for Diabetic Retinal Diseases Shows Promise

Exonate Ltd., a pioneering mRNA therapy company specializing in treatments for diabetic diseases, ha...

read more
First Topical Treatment for Diabetic Retinal Diseases Shows Promise
November 29, 2023
Researchers Develop Contact Lenses That Respond to UV and Temperature Changes

A team of researchers at Khalifa University has developed state-of-the-art UV protective contact len...

read more
Researchers Develop Contact Lenses That Respond to UV and Temperature Changes
November 29, 2023
FDA Requests Further Study on Aldeyra Therapeutics’ Reproxalap for DED

Aldeyra Therapeutics announced the receipt of a Complete Response Letter from the U.S. Food and Drug...

read more
FDA Requests Further Study on Aldeyra Therapeutics’ Reproxalap for DED
November 28, 2023
Researchers Develop Glaucoma Cell Replacement Therapy to Reverse Vision Loss

Glaucoma, a leading global cause of blindness, results in irreversible vision loss due to the deplet...

read more
Researchers Develop Glaucoma Cell Replacement Therapy to Reverse Vision Loss
November 20, 2023
FDA Issues Warning to Amazon Over Sale of 7 Unapproved Eye Drops

The US Food and Drug Administration's (FDA) Center for Drug Evaluation and Research (CDER) has issue...

read more
FDA Issues Warning to Amazon Over Sale of 7 Unapproved Eye Drops
November 15, 2023
Regeneron Files Lawsuit Against Celltrion Over Biosimilar Version of Eylea

Regeneron Pharmaceuticals Inc. has taken legal action against Celltrion Inc., filing a lawsuit to pr...

read more
Regeneron Files Lawsuit Against Celltrion Over Biosimilar Version of Eylea
November 13, 2023
Medical Breakthrough: World’s First Whole-eye and Partial Face Transplant

A surgical team comprising more than 140 clinicians, including surgeons, nurses, and various healthc...

read more
Medical Breakthrough: World’s First Whole-eye and Partial Face Transplant
November 10, 2023
FDA Approves Genentech’s Vabysmo for Treatment of Retinal Vein Occlusion

The FDA has approved Genentech's Vabysmo (faricimab-svoa) for the treatment macular edema following ...

read more
FDA Approves Genentech’s Vabysmo for Treatment of Retinal Vein Occlusion
October 30, 2023
FDA Warns of 26 Over-the-Counter Eye Drops from Several Major Brands

The FDA has issued a warning not to purchase or use 26 over-the-counter eye drop products due to the...

read more
FDA Warns of 26 Over-the-Counter Eye Drops from Several Major Brands
October 30, 2023
FDA Approves Samsung Bioepis’ Byooviz Biosimilar to Lucentis

Samsung Bioepis has announced that the FDA has granted approval for the supplemental biologics licen...

read more
FDA Approves Samsung Bioepis’ Byooviz Biosimilar to Lucentis
October 25, 2023
More